Base Career helps you apply smarter for this job.
Omeros is seeking a Scientist, Analytical Sciences (Mass Spectrometry ) to provide strategic and technical leadership for biological mass spectrometry-related activities across Analytical Sciences and Quality Control.
This individual will be part of a growing team of scientists responsible for the development and GMP oversight of mass spectrometry and liquid chromatography assays supporting clinical and commercial products.
The Scientist will develop, execute, and manage methods used for clinical and commercial testing to support CMC, Discovery, Quality Assurance, Regulatory Affairs, and corporate objectives. The scope of this role includes mass spectrometry and liquid chromatography related support for all phases of product development, including clinical and commercial programs, with emphasis on biologics peptide mapping, intact mass determination, mass spectrometry (MS) related host cell protein (HCP) quantification, and other analytical methods used to assess extended characterization, product quality, biological activity, and release/stability attributes.
Good things are happening at Omeros!
Who is Omeros?
Omeros is an innovative biotechnology company that discovers, develops, and commercializes first-in-class small-molecule and protein therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead lectin pathway inhibitor YARTEMLEA®, which inhibits the pathway’s effector enzyme MASP-2, is FDA-approved for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adult and pediatric patients ages two years and older, with a planned U.S. launch in January 2026. A marketing authorization application for YARTEMLEA in TA-TMA is currently under review by the European Medicines Agency, with a decision expected in mid-2026. OMS1029, Omeros’ long-acting MASP-2 inhibitor, has successfully completed Phase 1 clinical trials.
Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS906), a MASP-3 inhibitor in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets.
Omeros’ pipeline also includes OMS527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder and fully funded by the National Institute on Drug Abuse, as well as a growing portfolio of novel molecular and cellular oncology programs.
For more information about Omeros and its programs, visit www.omeros.com.
Skip the repetitive application forms
Install the Base Career Chrome Extension and autofill job applications across major job boards with your profile.
Trusted by over 500,000 job seekers on Base Career
More from this employer
, USA
Blood & Marrow Transplant Nurse Educator West Region Omeros is currently recruiting a Blood & Marrow Transplant Nurse Educator for the West Region. The Nurse Educator serves as a field-based clinical education resource f
Seattle, USA
Clinical Trial Manager The Clinical Trial Manager (CTM) works closely with various internal team members and vendors as well as clinical study sites to ensure that clinical trials are conducted in a timely fashion and in
, USA
Blood & Marrow Transplant Clinical Account Manager Omeros is currently recruiting a Blood & Marrow Transplant Clinical Account Manager to join our Launch Team of dynamic sales professionals. Reporting to the Regional Bus
, USA
Blood & Marrow Transplant Nurse Educator Northeast Region Omeros is currently recruiting a Blood & Marrow Transplant Nurse Educator for the Northeast Region. The Nurse Educator serves as a field-based clinical education
, USA
Blood & Marrow Transplant Nurse Educator Southeast Region Omeros is currently recruiting a Blood & Marrow Transplant Nurse Educator for the Southeast Region. The Nurse Educator serves as a field-based clinical education
, USA
Blood & Marrow Transplant Nurse Educator Central Region Omeros is currently recruiting a Blood & Marrow Transplant Nurse Educator for the Central Region. The Nurse Educator serves as a field-based clinical education reso
, USA
Seattle, USA
, USA
, USA
, USA
, USA
Seattle, USA
, USA
include:
Omeros is proud to offer a competitive total compensation package designed to support the lives of our employees and their families.
The wage scale for this position is $105,000 - $130,000.
Salaries will be determined based on knowledge, skills, education, and experience relevant to the role.
Employees are offered medical, dental, vision, life insurance, and a 401(k) plan with a company match.
Employees accrue three weeks of vacation and 80 hours of sick time on an annual basis and receive twelve paid holidays throughout the calendar year.
This position is eligible for incentive and stock options.
To learn more about Omeros, please visit www.omeros.com.
Omeros is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to status as a protected veteran or a qualified individual with a disability, or other protected status such as race, religion, color, national origin, sex, age, marital status, or any other factor determined to be unlawful by federal, state, or local statutes.
It is our policy to provide reasonable accommodation to anyone with a disability who needs assistance completing the job application process.
If you need assistance, you can either send an e-mail to hr@omeros.com or contact Omeros, asking for Human Resources, at (206) 676-5000.
To perform this job successfully, an individual must be able to perform each essential duty satisfactorily.
The requirements listed above are representative of the knowledge, skills, and/or abilities required.
Reasonable accommodation may be made to enable individuals with disabilities to perform the essential functions.
Verified company details for this employer are not available yet.
USD 105000-130000 yearly
Full-time
Senior Level
Onsite
Apply faster on company sites with our extension.